Abstract:
The monitoring of patients with human immunodeficiency virus (HIV) infection who are treated
with antiretroviral medications in resource-limited settings is typically performed by use of clinical and immunological
criteria. The early identification of first-line antiretroviral treatment failure is critical to prevent morbidity,
mortality, and drug resistance. Misclassification of failure may result in premature switching to second-line therapy